Healthcare Professional Resources

Explore resources tailored to support your everyday practice.

Burden of CKD

Economic impact of CKD 

Summary of Deloitte Access Economics Report for Kidney Health Australia

Deloitte Access Economics Report for Kidney Health Australia

INSIDE CKD: Economic Impact
 

Role of Primary Care in CKD

CKD screening & diagnosis

CKD management guidelines

Chronic Kidney Disease (CKD) Management in Primary Care Handbook




Highlights of the KDIGO 2024 Clinical Practice Guideline Update

Prof. Magdalena Madero, co-author of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD, shares a summary of the key updates to the guidelines.

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease




CARI Guidelines

Monitoring Gaps in Guideline Adherence

Evidence for Dapagliflozin in CKD

Insights into the DAPA-CKD trial and relevance of its outcomes

Professor David C Wheeler provides an overview of the DAPA-CKD trial and its role in changing clinical practice for the treatment of CKD.

DAPA-CKD outcomes in patient with and without T2D

Professor David C Wheeler highlights the relevance of DAPA-CKD results for nephrologists in their practice for patients with and without type 2 diabetes.

How can we implement DAPA-CKD in clinical practice?

Professor David C Wheeler discusses patient selection in the DAPA-CKD trial and how these learnings can be applied in your clinical practice.

Practical implications of treating patients with CKD

Professor David C Wheeler discusses the practical implications for nephrologists treating patients with CKD and the safety profile of dapagliflozin.

DAPA-CKD
Clinical Trial Summary





Research Review: Efficacy and Safety of Dapagliflozin in Patients with CKD, HF, and T2D




Presentation: DAPA-CKD - Dapagliflozin in Patients with Chronic Kidney Disease
 

Patient Resources

Access helpful resources to share with your patients.

You might also be interested in

Cardiovascular Hub

Explore resources for the diagnosis and management of heart failure and cardiovascular disease.

Metabolic Hub

Explore resources for the diagnosis and management of type 2 diabetes.
 

Forxiga®

Learn more about Forxiga® in chronic kidney disease here.
 

 

Abbreviations: CKD, chronic kidney disease; GP, general practitioner; HF, heart failure; KDIGO, Kidney Disease: Improving Global Outcomes; TIMI, thrombolysis in myocardial infarction; T2D, Type 2 diabetes.

Want to know more?

If you have any questions or would like to be kept updated on new training
resources please subscribe to our email newsletter or reach out below.

 

Loading......